BioCentury
ARTICLE | Financial News

ElsaLys Biotech completes venture financing

November 9, 2015 8:00 AM UTC

ElsaLys Biotech, Lyon, France Business: Antibodies, Cancer, Inflammation Date completed: 2015-11-03 Type: Venture financing Raised: EUR2.7 million ($3 million) Investors: Sofimac; Institut Merieux; C...